Literature DB >> 1945626

Risk of seizures after measles-mumps-rubella immunization.

M R Griffin1, W A Ray, E A Mortimer, G M Fenichel, W Schaffner.   

Abstract

To evaluate the risks of seizures and other neurologic events following measles-mumps-rubella (MMR) or measles-rubella (MR) immunization, a retrospective cohort study was conducted among 18,364 Tennessee children enrolled in Medicaid who received MMR or MR immunizations in their first 3 years of life. One hundred children had seizures at some time between immunization and 36 months; there were no encephalopathies during this period. Four children had febrile seizures in the 7 through 14 days following MMR or MR immunization compared with 72 in the interval 30 or more days following MMR or MR immunization yielding a relative risk (95% confidence interval) of 2.1 (0.7 to 6.4). Although not statistically significant, this increase in febrile seizures in the 7- through 14-day interval following MMR immunization is coincident with the occurrence of fever following MMR immunization and is consistent with reports of other investigators.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1945626

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  15 in total

1.  A postmarket safety comparison of 2 vaccination strategies for measles, mumps, rubella and varicella in Italy.

Authors:  Silvia Cocchio; Giovanna Zanoni; Roberta Opri; Francesca Russo; Vincenzo Baldo
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

2.  The reporting sensitivities of two passive surveillance systems for vaccine adverse events.

Authors:  S Rosenthal; R Chen
Journal:  Am J Public Health       Date:  1995-12       Impact factor: 9.308

3.  Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.

Authors:  Pedro A Piedra; Manjusha J Gaglani; Mark Riggs; Gayla Herschler; Charles Fewlass; Matt Watts; Claudia Kozinetz; Colin Hessel; W Paul Glezen
Journal:  Pediatrics       Date:  2005-09       Impact factor: 7.124

4.  Hemiplegia after measles, mumps, and rubella vaccination.

Authors:  A H Sackey; R L Broadhead
Journal:  BMJ       Date:  1993-05-01

Review 5.  Vaccines for measles, mumps and rubella in children.

Authors:  Vittorio Demicheli; Alessandro Rivetti; Maria Grazia Debalini; Carlo Di Pietrantonj
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

6.  Measles vaccination of special risk groups.

Authors:  Vassiliki Papaevangelou
Journal:  Hum Vaccin Immunother       Date:  2021-11-17       Impact factor: 3.452

Review 7.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2021-11-22

Review 8.  Placing the risk of seizures with pediatric vaccines in a clinical context.

Authors:  Robert L Davis; William Barlow
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

9.  Seizure Risk with Vaccination.

Authors:  Anne T. Berg
Journal:  Epilepsy Curr       Date:  2002-01       Impact factor: 7.872

10.  Prevalence of SCN1A-related dravet syndrome among children reported with seizures following vaccination: a population-based ten-year cohort study.

Authors:  Nienke E Verbeek; Nicoline A T van der Maas; Floor E Jansen; Marjan J A van Kempen; Dick Lindhout; Eva H Brilstra
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.